Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OLT1177 Gel in Knee Osteoarthritis Pain
NCT02104050Phase 2Completed
- Sponsor
- Olatec Therapeutics LLC
- Start
- Apr 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) comparing OLT1177 Gel with Placebo Gel (2 arms). Primary endpoint: Pain on Movement at 6 weeks. Started Apr 2014; status: completed.
02
Drugs
dapansutrile
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02104050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104050.